CS197387B1 - Pharmaceutical mixture for decreasing the cholesterole level in the blood - Google Patents

Pharmaceutical mixture for decreasing the cholesterole level in the blood Download PDF

Info

Publication number
CS197387B1
CS197387B1 CS736877A CS687773A CS197387B1 CS 197387 B1 CS197387 B1 CS 197387B1 CS 736877 A CS736877 A CS 736877A CS 687773 A CS687773 A CS 687773A CS 197387 B1 CS197387 B1 CS 197387B1
Authority
CS
Czechoslovakia
Prior art keywords
formula
represents hydrogen
compound
cholesterol
mixture
Prior art date
Application number
CS736877A
Other languages
Czech (cs)
English (en)
Inventor
Mitchell N Cayen
Dushan M Dvornik
Original Assignee
Mitchell N Cayen
Dushan M Dvornik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitchell N Cayen, Dushan M Dvornik filed Critical Mitchell N Cayen
Publication of CS197387B1 publication Critical patent/CS197387B1/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
CS736877A 1972-10-06 1973-10-05 Pharmaceutical mixture for decreasing the cholesterole level in the blood CS197387B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA153,515A CA985172A (en) 1972-10-06 1972-10-06 Compositions and methods for reducing blood cholesterol

Publications (1)

Publication Number Publication Date
CS197387B1 true CS197387B1 (en) 1980-05-30

Family

ID=4094630

Family Applications (1)

Application Number Title Priority Date Filing Date
CS736877A CS197387B1 (en) 1972-10-06 1973-10-05 Pharmaceutical mixture for decreasing the cholesterole level in the blood

Country Status (16)

Country Link
US (1) US3890438A (xx)
AU (1) AU477269B2 (xx)
BE (1) BE805634A (xx)
CA (1) CA985172A (xx)
CS (1) CS197387B1 (xx)
DD (1) DD106948A5 (xx)
DE (1) DE2348176A1 (xx)
ES (1) ES419355A1 (xx)
FR (1) FR2201893B1 (xx)
GB (1) GB1439625A (xx)
HU (1) HU169814B (xx)
IE (1) IE38274B1 (xx)
IN (1) IN138921B (xx)
NL (1) NL7313519A (xx)
SE (1) SE403886B (xx)
ZA (1) ZA737246B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3838716A1 (de) * 1988-11-15 1990-05-17 Kanoldt Arzneimittel Gmbh Arzneimittelzubereitung aus esterderivaten des hecogenins und dessen verwendung zur behandlung von benigner prostatahyperplasie
US6929807B1 (en) * 1996-08-09 2005-08-16 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements
ATE314057T1 (de) * 1998-03-26 2006-01-15 Phytopharm Plc Smilagenin und anzurogenin-d zur behandlung der alzheimerischen krankheit
US20030118673A1 (en) * 1998-03-26 2003-06-26 Zongqin Xia Smilagenin and anzurogenin-D for the treatment of alzheimer's disease
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB2347676A (en) * 1999-03-08 2000-09-13 Phytopharm Plc Screening method
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
WO2003022287A1 (fr) * 2001-08-24 2003-03-20 Jilin Tianyao Science And Technology Co. Ltd. UTILISATION DE 3β-HYDROXY-5-SPIROSTENE POUR PREVENIR OU TRAITER DES MALADIES OU DES ETATS CARDIO-VASCULAIRES, INHIBER DES TUMEURS ET REDUIRE LES LIPIDES SANGUINS
KR101130212B1 (ko) * 2002-03-27 2012-04-13 파이토팜 피엘씨 사포게닌 및 그 유도체의 치료 방법 및 사용법
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives
WO2003086411A1 (fr) * 2002-04-15 2003-10-23 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Composes et techniques de preparation de carboxylate de diosgenine et d'un derive de succinate monoester de diosgenine
GB0409567D0 (en) 2004-04-28 2004-06-02 Phytopharm Plc Chemical compounds
US20090208588A1 (en) * 2008-02-19 2009-08-20 Roger Wayne Brown GERD carbohydrate compositions
US20090209489A1 (en) * 2008-02-19 2009-08-20 Roger Wayne Brown Compositions for the treatment of diabetis, system PH disorders, high blood pressure, and a cancer marker system
US20090209486A1 (en) * 2008-02-19 2009-08-20 Roger Wayne Brown Compositions of carbohydrates as dietary supplements
US20090209488A1 (en) * 2008-02-19 2009-08-20 Roger Wayne Brown Compositions for the treatment of exercise induced asthma
EP2595621A1 (en) 2010-07-20 2013-05-29 Phytopharm PLC Treatment of l-dopa, dopamine agonist and/or dopamine enhancer induced disorders
FR3133158A1 (fr) 2022-03-04 2023-09-08 Psa Automobiles Sa Procédé de gestion énergetique d’une prise d’alimentation d’accessoire dans un véhicule automobile à l’arrêt

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE630211A (xx) * 1962-03-28

Also Published As

Publication number Publication date
DE2348176A1 (de) 1974-04-11
ES419355A1 (es) 1976-03-01
AU6110873A (en) 1975-04-10
FR2201893A1 (xx) 1974-05-03
HU169814B (xx) 1977-02-28
US3890438A (en) 1975-06-17
DD106948A5 (xx) 1974-07-12
GB1439625A (en) 1976-06-16
AU477269B2 (en) 1976-10-21
BE805634A (fr) 1974-04-03
FR2201893B1 (xx) 1977-09-09
CA985172A (en) 1976-03-09
SE403886B (sv) 1978-09-11
NL7313519A (xx) 1974-04-09
ZA737246B (en) 1975-04-30
IE38274L (en) 1974-04-06
IE38274B1 (en) 1978-02-01
IN138921B (xx) 1976-04-17

Similar Documents

Publication Publication Date Title
CS197387B1 (en) Pharmaceutical mixture for decreasing the cholesterole level in the blood
US9775910B2 (en) Stable aqueous suspension
EP1022022B1 (en) Composition for inhibiting increase of blood sugar level or lowering blood sugar level
WO1997047209A1 (fr) Amelioration du metabolisme lipidique
US20210008088A1 (en) Composition for preventing or treating non-alcoholic liver disease or insulin resistance comprising ginsenoside f2
US20190358281A1 (en) Composition Comprising Retinol, a Precursor or a Reaction Product of it and a Plant Extract from at least one Chamomilla Plant for the Treatment of Cancer
US3800051A (en) Reducing serum cholesterol with certain substituted phenols
JP5451403B2 (ja) アドレノメデュリン産生増強剤
JP2008222656A (ja) 肥満改善および予防用組成物ならびに健康食品
JP7154616B2 (ja) 骨関連疾患の予防または治療のための薬学組成物
WO2006102788A1 (fr) Les hypolipemiants complexes
US20240197665A1 (en) Pharmaceutical Composition For Treating Hyperlipidemia And Preparation Method Therefor
US12042520B2 (en) Compositions containing curcumin having improved bioavailability
CA3060214A1 (en) Modified release nicotinamide
EP1776956B1 (en) Preventive and/or therapeutic agent for calcipenia
CN107648307B (zh) 一种组合物、其制备方法和应用
US11684618B2 (en) Compositions comprising mixtures of compounds and uses thereof
JP2007297367A (ja) 血圧上昇を抑制する組成物、薬剤及び機能性食品
KR101889418B1 (ko) 20(s)-프로토파낙사디올 또는 이의 염을 유효성분으로 포함하는 테모졸로마이드의 항암활성 증진용 조성물
JP2024022770A (ja) 慢性腎臓病の予防、改善又は治療用組成物
WILCOX et al. Department of Biological Chemistry University of Utah College of Medicine Salt Lake City, Utah
TW200840590A (en) Compositions and methods for prevention and treatment of cachexia